Jed A. Latkin
Overview
Jed A. Latkin received an average of $849K in total compensation, including $368K in salary, at Navidea Biopharmaceuticals from 2016 to 2021.
2021Navidea BiopharmaceuticalsFormer Chief Executive Officer, Chief Operating Officer and Chief Financial Officer
2020Navidea BiopharmaceuticalsChief Executive Officer, Chief Operating Officer and Chief Financial Officer
2019Navidea BiopharmaceuticalsChief Executive Officer, Chief Operating Officer and Chief Financial Officer
2018Navidea BiopharmaceuticalsChief Executive Officer, Chief Operating Officer and Chief Financial Officer
2017Navidea BiopharmaceuticalsChief Executive Officer, Chief Operating Officer and Chief Financial Officer
2016Navidea BiopharmaceuticalsChief Operating Officer and Chief Financial Officer
Source: SEC filings on October 24, 2022, August 2, 2021, July 31, 2020, June 28, 2019, and May 24, 2017.
Related executives
We found 17 more executives who work or worked at Navidea Biopharmaceuticals.
Michael Rosol
Navidea Biopharmaceuticals
Chief Medical Officer
Erika Eves
Navidea Biopharmaceuticals
Vice President, Finance & Administration
Michel Mikhail
Navidea Biopharmaceuticals
Chief Regulatory Officer
Joel Kaufman
Navidea Biopharmaceuticals
Former Chief Business Officer
Michael Goldberg
Navidea Biopharmaceuticals
Chief Executive Officer
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
Thomas Klima
Navidea Biopharmaceuticals
Senior Vice President and Chief Commercial Officer
William Regan
Navidea Biopharmaceuticals
Senior Vice President and Chief Compliance Officer
News
Navidea Biopharmaceuticals CEO Jed Latkin's 2021 pay rises 10% to $1.3M
October 24, 2022
Navidea Biopharmaceuticals CEO Jed Latkin's 2020 pay jumps 66% to $1.2M
August 2, 2021
Navidea Biopharmaceuticals CEO Jed Latkin's 2019 pay rises 16% to $740K
July 31, 2020
Navidea Biopharmaceuticals CEO Michael Goldberg's 2018 pay jumps 76% to $1.5M
June 28, 2019